REFERENCES
- Saada , A. , Shaag , A. , Mandel , H. , Nevo , Y. , Eriksson , S. and Elpeleg , O. 2001 . Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy . Nat. Genet. , 29 : 342 – 324 .
- Saada , A. , Shaag , A. and Elpeleg , O. 2003 . mtDNA depletion myopathy: elucidation of the tissue specificity in the mitochondrial thymidine kinase (TK2) deficiency . Mol. Genet. Metab. , 79 : 1 – 5 .
- Wang , L. , Saada , A. and Eriksson , S. 2003 . Kinetic properties of mutant human thymidine kinase 2 suggest a mechanism for mitochondrial DNA depletion myopathy . J. Biol. Chem. , 278 : 6963 – 6968 .
- Wang , L. , Munch-Petersen , B. , Herrström Sjöberg , A. , Hellman , U. , Bergman , T. , Jörnvall , H. and Eriksson , S. 1999 . Human thymidine kinase 2: molecular cloning and characterisation of the enzyme activity with antiviral and cytostatic nucleoside substrates . FEBS Lett. , 443 : 170 – 174 .
- Graham , J. C. 1999 . “ Subcellular fractionation and isolation of organelles ” . In Current protocols in Cell Biology , 3.3.1 – 3.3.15 . New York : John Wiley & Sons .
- Wang , L. , Karlsson , A. , Arnér , E. S.J. and Eriksson , S. 1993 . Substrate specificity of mitochondrial 2′-deoxyguanosine kinase Efficient phosphorylation of 2-chlorodeoxyadenosine . J. Biol. Chem. , 268 : 22847 – 22852 .